Definitive treatment vs. active surveillance for small renal masses: Closing the preference gap
Can Urol Assoc J
.
2022 Apr;16(4):102-103.
doi: 10.5489/cuaj.7841.
Authors
Kiran Sury
1
,
Phillip M Pierorazio
1
Affiliation
1
Division of Urology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.
PMID:
35358412
PMCID:
PMC9054337
DOI:
10.5489/cuaj.7841
No abstract available